Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Pancreatic Ductal | 31 | 2024 | 1728 | 4.140 |
Why?
|
Pancreatic Neoplasms | 46 | 2024 | 5369 | 3.970 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 24 | 2024 | 1745 | 3.870 |
Why?
|
ras Proteins | 2 | 2022 | 1054 | 1.020 |
Why?
|
Leucovorin | 2 | 2024 | 643 | 0.990 |
Why?
|
Acetonitriles | 2 | 2024 | 54 | 0.980 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2022 | 2872 | 0.830 |
Why?
|
Fluorouracil | 2 | 2024 | 1642 | 0.800 |
Why?
|
Protein Phosphatase 1 | 1 | 2022 | 134 | 0.790 |
Why?
|
Oncogenes | 4 | 2022 | 1222 | 0.780 |
Why?
|
Drug Resistance, Neoplasm | 9 | 2024 | 5305 | 0.760 |
Why?
|
MAP Kinase Signaling System | 6 | 2022 | 1486 | 0.750 |
Why?
|
Mutation | 28 | 2024 | 30054 | 0.730 |
Why?
|
Deoxycytidine | 2 | 2024 | 877 | 0.730 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 150 | 0.670 |
Why?
|
Cell Line, Tumor | 33 | 2024 | 16986 | 0.660 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2020 | 195 | 0.650 |
Why?
|
Paclitaxel | 3 | 2024 | 1732 | 0.620 |
Why?
|
Pyrimidines | 5 | 2024 | 3028 | 0.610 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 650 | 0.610 |
Why?
|
Adenocarcinoma | 14 | 2024 | 6346 | 0.600 |
Why?
|
Genomics | 8 | 2024 | 5821 | 0.590 |
Why?
|
Neoplasms | 21 | 2024 | 22173 | 0.590 |
Why?
|
Guanosine Triphosphate | 5 | 2024 | 316 | 0.570 |
Why?
|
Antineoplastic Agents | 13 | 2024 | 13642 | 0.570 |
Why?
|
Gene Expression Profiling | 12 | 2024 | 9420 | 0.550 |
Why?
|
Multiprotein Complexes | 1 | 2022 | 1120 | 0.520 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2024 | 11742 | 0.510 |
Why?
|
Gene Expression Regulation, Neoplastic | 19 | 2024 | 8552 | 0.510 |
Why?
|
Piperazines | 3 | 2024 | 2523 | 0.490 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1246 | 0.470 |
Why?
|
Gene Dosage | 4 | 2016 | 1218 | 0.450 |
Why?
|
Colorectal Neoplasms | 7 | 2024 | 6935 | 0.440 |
Why?
|
Gene Targeting | 2 | 2016 | 838 | 0.430 |
Why?
|
Iron-Sulfur Proteins | 2 | 2022 | 83 | 0.400 |
Why?
|
Tumor Microenvironment | 9 | 2023 | 3877 | 0.390 |
Why?
|
Genes, ras | 4 | 2024 | 654 | 0.380 |
Why?
|
Appendiceal Neoplasms | 2 | 2023 | 155 | 0.350 |
Why?
|
Protein Kinase Inhibitors | 9 | 2023 | 5672 | 0.330 |
Why?
|
Stomach Neoplasms | 3 | 2024 | 1459 | 0.330 |
Why?
|
Lung Neoplasms | 10 | 2024 | 13382 | 0.320 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2024 | 3603 | 0.310 |
Why?
|
Signal Transduction | 12 | 2024 | 23447 | 0.310 |
Why?
|
Tumor Suppressor Protein p14ARF | 3 | 2006 | 84 | 0.310 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2735 | 0.300 |
Why?
|
Cell Proliferation | 13 | 2024 | 10448 | 0.290 |
Why?
|
Humans | 91 | 2024 | 761572 | 0.290 |
Why?
|
Albumins | 3 | 2024 | 575 | 0.280 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2006 | 698 | 0.280 |
Why?
|
Animals | 41 | 2024 | 168467 | 0.270 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2020 | 2917 | 0.270 |
Why?
|
Mice | 32 | 2024 | 81533 | 0.260 |
Why?
|
Proto-Oncogene Proteins | 3 | 2023 | 4513 | 0.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 5315 | 0.240 |
Why?
|
HCT116 Cells | 3 | 2021 | 404 | 0.230 |
Why?
|
Benzimidazoles | 2 | 2021 | 858 | 0.230 |
Why?
|
raf Kinases | 2 | 2022 | 118 | 0.230 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2024 | 68 | 0.230 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 899 | 0.230 |
Why?
|
DNA Copy Number Variations | 3 | 2024 | 2020 | 0.230 |
Why?
|
Genetic Predisposition to Disease | 6 | 2020 | 17904 | 0.220 |
Why?
|
Gene Knockout Techniques | 2 | 2017 | 802 | 0.220 |
Why?
|
Protein Stability | 2 | 2022 | 578 | 0.210 |
Why?
|
Genetic Variation | 1 | 2018 | 6567 | 0.210 |
Why?
|
Haptens | 1 | 2022 | 163 | 0.210 |
Why?
|
Single-Cell Analysis | 4 | 2021 | 2450 | 0.210 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 86 | 0.200 |
Why?
|
Pyridines | 3 | 2024 | 2875 | 0.200 |
Why?
|
DNA Repair | 3 | 2021 | 2046 | 0.200 |
Why?
|
Receptor, IGF Type 1 | 2 | 2023 | 380 | 0.200 |
Why?
|
Crk-Associated Substrate Protein | 1 | 2021 | 39 | 0.190 |
Why?
|
Gene Regulatory Networks | 3 | 2021 | 1745 | 0.190 |
Why?
|
GTP Phosphohydrolases | 2 | 2024 | 517 | 0.190 |
Why?
|
Neoplasm Proteins | 4 | 2018 | 3617 | 0.190 |
Why?
|
Nissl Bodies | 1 | 2020 | 16 | 0.180 |
Why?
|
Nerve Tissue | 1 | 2021 | 78 | 0.180 |
Why?
|
Ameloblastoma | 1 | 2021 | 42 | 0.180 |
Why?
|
src-Family Kinases | 2 | 2021 | 535 | 0.180 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2021 | 129 | 0.180 |
Why?
|
Jaw Neoplasms | 1 | 2021 | 70 | 0.180 |
Why?
|
Smad4 Protein | 1 | 2021 | 191 | 0.180 |
Why?
|
Mice, Hairless | 1 | 2019 | 39 | 0.170 |
Why?
|
Amino Acid Motifs | 1 | 2022 | 931 | 0.170 |
Why?
|
Pinocytosis | 1 | 2019 | 62 | 0.170 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2023 | 489 | 0.170 |
Why?
|
Neoplasms, Experimental | 3 | 2020 | 1229 | 0.160 |
Why?
|
Myeloid Cells | 2 | 2021 | 823 | 0.160 |
Why?
|
Codon | 1 | 2021 | 601 | 0.160 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 615 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2021 | 586 | 0.160 |
Why?
|
Neuregulin-1 | 1 | 2019 | 135 | 0.160 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2018 | 56 | 0.150 |
Why?
|
Organoids | 3 | 2021 | 743 | 0.150 |
Why?
|
Cell-Penetrating Peptides | 1 | 2018 | 49 | 0.150 |
Why?
|
Fusobacterium | 1 | 2017 | 53 | 0.150 |
Why?
|
Mice, SCID | 2 | 2019 | 2626 | 0.140 |
Why?
|
Molecular Targeted Therapy | 3 | 2024 | 2811 | 0.140 |
Why?
|
Ketoglutarate Dehydrogenase Complex | 1 | 2017 | 21 | 0.140 |
Why?
|
Enteric Nervous System | 1 | 2020 | 212 | 0.140 |
Why?
|
Neurosciences | 1 | 2022 | 367 | 0.140 |
Why?
|
Receptor, erbB-2 | 2 | 2024 | 2557 | 0.140 |
Why?
|
Anilides | 1 | 2020 | 411 | 0.140 |
Why?
|
Gene Amplification | 2 | 2024 | 1089 | 0.140 |
Why?
|
Colonic Polyps | 1 | 2021 | 554 | 0.140 |
Why?
|
Peritoneal Neoplasms | 1 | 2023 | 711 | 0.140 |
Why?
|
Lipid Peroxidation | 1 | 2017 | 271 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 2 | 2024 | 6484 | 0.130 |
Why?
|
Neoplasm Metastasis | 2 | 2024 | 4915 | 0.130 |
Why?
|
Metronidazole | 1 | 2017 | 232 | 0.130 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 655 | 0.130 |
Why?
|
Protein Conformation | 2 | 2021 | 3968 | 0.130 |
Why?
|
Membrane Proteins | 3 | 2024 | 7858 | 0.130 |
Why?
|
Glutathione Peroxidase | 1 | 2017 | 258 | 0.130 |
Why?
|
DNA Cleavage | 1 | 2016 | 56 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2057 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 988 | 0.130 |
Why?
|
p21-Activated Kinases | 2 | 2023 | 128 | 0.130 |
Why?
|
Genomic Instability | 1 | 2019 | 709 | 0.130 |
Why?
|
Microtubules | 1 | 2021 | 1074 | 0.130 |
Why?
|
RNA Splicing | 1 | 2020 | 918 | 0.130 |
Why?
|
Prognosis | 7 | 2024 | 29629 | 0.120 |
Why?
|
Cysteine | 1 | 2020 | 891 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 954 | 0.120 |
Why?
|
Genes, Essential | 1 | 2016 | 185 | 0.120 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2019 | 423 | 0.120 |
Why?
|
Antigens, Protozoan | 1 | 2017 | 316 | 0.120 |
Why?
|
Phosphorylation | 2 | 2023 | 8321 | 0.120 |
Why?
|
Mutagenesis | 1 | 2018 | 1232 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2425 | 0.120 |
Why?
|
Esophageal Neoplasms | 1 | 2024 | 1654 | 0.110 |
Why?
|
Inservice Training | 1 | 2016 | 375 | 0.110 |
Why?
|
Body Composition | 1 | 2023 | 2426 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1315 | 0.110 |
Why?
|
Binding Sites | 1 | 2022 | 6056 | 0.110 |
Why?
|
DNA Damage | 3 | 2020 | 2449 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2020 | 0.110 |
Why?
|
Aged | 13 | 2024 | 169310 | 0.110 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1858 | 0.110 |
Why?
|
Mutation, Missense | 1 | 2022 | 2571 | 0.110 |
Why?
|
Protein Binding | 2 | 2022 | 9353 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2016 | 415 | 0.110 |
Why?
|
Tumor Cells, Cultured | 4 | 2020 | 6132 | 0.110 |
Why?
|
Apoptosis | 4 | 2024 | 9489 | 0.100 |
Why?
|
Oligopeptides | 1 | 2018 | 1187 | 0.100 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2020 | 718 | 0.100 |
Why?
|
Male | 24 | 2024 | 360842 | 0.100 |
Why?
|
Chromosome Mapping | 2 | 2022 | 4615 | 0.100 |
Why?
|
Nuclear Receptor Coactivators | 2 | 2022 | 61 | 0.100 |
Why?
|
Sulfur | 2 | 2022 | 162 | 0.100 |
Why?
|
Proteomics | 3 | 2020 | 3848 | 0.100 |
Why?
|
Biological Availability | 2 | 2022 | 390 | 0.100 |
Why?
|
Middle Aged | 13 | 2024 | 220920 | 0.100 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3430 | 0.100 |
Why?
|
Transcription Factors | 5 | 2022 | 12129 | 0.090 |
Why?
|
Genome, Human | 3 | 2016 | 4425 | 0.090 |
Why?
|
Clinical Laboratory Techniques | 1 | 2016 | 746 | 0.090 |
Why?
|
Female | 25 | 2024 | 392686 | 0.090 |
Why?
|
Mice, Nude | 4 | 2021 | 3614 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 934 | 0.090 |
Why?
|
Structure-Activity Relationship | 3 | 2020 | 3076 | 0.090 |
Why?
|
Genome | 3 | 2023 | 1740 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2024 | 4026 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3612 | 0.080 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22172 | 0.080 |
Why?
|
Weight Loss | 1 | 2020 | 2684 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2017 | 2827 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9280 | 0.080 |
Why?
|
Nucleic Acid Hybridization | 3 | 2005 | 1302 | 0.080 |
Why?
|
Gene Expression | 2 | 2016 | 7581 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2538 | 0.080 |
Why?
|
Iron | 3 | 2022 | 1793 | 0.080 |
Why?
|
Neoadjuvant Therapy | 3 | 2024 | 2827 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2005 | 3778 | 0.070 |
Why?
|
rho GTP-Binding Proteins | 1 | 2008 | 276 | 0.070 |
Why?
|
Computational Biology | 3 | 2021 | 3517 | 0.070 |
Why?
|
Pancreatic Ducts | 1 | 2008 | 329 | 0.070 |
Why?
|
Nanoparticles | 1 | 2018 | 1959 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2017 | 2882 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3713 | 0.070 |
Why?
|
Pyrimidinones | 2 | 2020 | 385 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2759 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2017 | 2986 | 0.060 |
Why?
|
Molecular Structure | 2 | 2020 | 1880 | 0.060 |
Why?
|
Adult | 9 | 2024 | 221203 | 0.060 |
Why?
|
Nuclear Proteins | 3 | 2021 | 5799 | 0.060 |
Why?
|
Pancreas | 2 | 2024 | 1691 | 0.060 |
Why?
|
Stromal Cells | 2 | 2021 | 1330 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2020 | 12794 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2023 | 5146 | 0.060 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6214 | 0.060 |
Why?
|
Pancreatectomy | 2 | 2020 | 811 | 0.060 |
Why?
|
Cell Death | 2 | 2021 | 1679 | 0.060 |
Why?
|
CA-19-9 Antigen | 1 | 2024 | 106 | 0.060 |
Why?
|
Genes, p53 | 1 | 2006 | 712 | 0.060 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 75 | 0.050 |
Why?
|
Down-Regulation | 2 | 2021 | 2919 | 0.050 |
Why?
|
Respiration | 1 | 1990 | 1657 | 0.050 |
Why?
|
Pyridones | 2 | 2020 | 809 | 0.050 |
Why?
|
Homozygote | 2 | 2006 | 1776 | 0.050 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2023 | 186 | 0.050 |
Why?
|
Genes, myc | 1 | 2024 | 390 | 0.050 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2004 | 418 | 0.050 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2023 | 234 | 0.050 |
Why?
|
Gene Deletion | 3 | 2006 | 2665 | 0.050 |
Why?
|
Claudins | 1 | 2023 | 117 | 0.050 |
Why?
|
Esophagogastric Junction | 1 | 2024 | 347 | 0.050 |
Why?
|
Colon | 2 | 2020 | 1792 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 202 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2018 | 3639 | 0.050 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2022 | 115 | 0.050 |
Why?
|
Integrases | 1 | 2003 | 518 | 0.050 |
Why?
|
DNA, Neoplasm | 2 | 2023 | 1745 | 0.050 |
Why?
|
Chromosomes | 1 | 2004 | 578 | 0.050 |
Why?
|
Alleles | 3 | 2018 | 6864 | 0.050 |
Why?
|
Genes, p16 | 1 | 2001 | 160 | 0.050 |
Why?
|
Fibroblasts | 3 | 2014 | 4141 | 0.050 |
Why?
|
Neurons | 1 | 2020 | 9463 | 0.050 |
Why?
|
Endoplasmic Reticulum, Rough | 1 | 2020 | 21 | 0.050 |
Why?
|
Cell Compartmentation | 1 | 2021 | 384 | 0.050 |
Why?
|
Calpain | 1 | 2021 | 146 | 0.050 |
Why?
|
Spliceosomes | 1 | 2021 | 130 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15936 | 0.040 |
Why?
|
Muscular Atrophy | 1 | 2023 | 334 | 0.040 |
Why?
|
Micronucleus Tests | 1 | 2019 | 23 | 0.040 |
Why?
|
Mice, Knockout | 4 | 2020 | 14416 | 0.040 |
Why?
|
Half-Life | 1 | 2021 | 651 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 641 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 455 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 135 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4111 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58986 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9541 | 0.040 |
Why?
|
Ferritins | 1 | 2022 | 598 | 0.040 |
Why?
|
Acetamides | 1 | 2021 | 256 | 0.040 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 161 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7407 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6815 | 0.040 |
Why?
|
Edema | 1 | 2023 | 766 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2024 | 64684 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4280 | 0.040 |
Why?
|
Cohort Studies | 4 | 2023 | 41493 | 0.040 |
Why?
|
Methylation | 1 | 2021 | 1084 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 695 | 0.040 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9610 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 428 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2020 | 164 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2020 | 426 | 0.040 |
Why?
|
Heart Rate | 1 | 1990 | 4195 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 664 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 732 | 0.040 |
Why?
|
Morpholines | 1 | 2021 | 581 | 0.040 |
Why?
|
Ileum | 1 | 2020 | 557 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2021 | 3597 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 610 | 0.040 |
Why?
|
Prevotella | 1 | 2017 | 80 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2004 | 1768 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4580 | 0.040 |
Why?
|
Tubulin | 1 | 2021 | 693 | 0.040 |
Why?
|
HT29 Cells | 1 | 2017 | 193 | 0.040 |
Why?
|
Lipid Peroxides | 1 | 2017 | 74 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2021 | 7593 | 0.040 |
Why?
|
Bacteroides | 1 | 2017 | 165 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 959 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1756 | 0.040 |
Why?
|
Ribosomes | 1 | 2020 | 501 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2019 | 705 | 0.030 |
Why?
|
Phenotype | 3 | 2023 | 16592 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2021 | 726 | 0.030 |
Why?
|
Cytoplasm | 1 | 2021 | 1510 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12690 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2018 | 670 | 0.030 |
Why?
|
Inflammation | 3 | 2021 | 10773 | 0.030 |
Why?
|
Electrocardiography | 1 | 1990 | 6377 | 0.030 |
Why?
|
Ion Channels | 1 | 2021 | 1040 | 0.030 |
Why?
|
Viral Proteins | 1 | 2003 | 1804 | 0.030 |
Why?
|
Databases, Genetic | 2 | 2018 | 1742 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 2020 | 764 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10090 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2017 | 186 | 0.030 |
Why?
|
Actins | 1 | 2023 | 2050 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2021 | 842 | 0.030 |
Why?
|
Citric Acid Cycle | 1 | 2017 | 231 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2020 | 504 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2020 | 18965 | 0.030 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4319 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1962 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 996 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1827 | 0.030 |
Why?
|
Drug Design | 1 | 2020 | 1048 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1363 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 956 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2019 | 1699 | 0.030 |
Why?
|
Autophagy | 1 | 2022 | 1326 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 796 | 0.030 |
Why?
|
Standard of Care | 1 | 2018 | 551 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18253 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 370 | 0.030 |
Why?
|
Mesoderm | 1 | 2017 | 674 | 0.030 |
Why?
|
Organizational Policy | 1 | 2016 | 432 | 0.030 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1349 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 613 | 0.030 |
Why?
|
Pyrroles | 1 | 2019 | 1125 | 0.030 |
Why?
|
Cell Movement | 2 | 2020 | 5205 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2021 | 1974 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3579 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 835 | 0.030 |
Why?
|
Models, Biological | 2 | 2020 | 9469 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2726 | 0.030 |
Why?
|
Patient Care Team | 1 | 2024 | 2521 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2003 | 3492 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2018 | 1189 | 0.030 |
Why?
|
Cadherins | 1 | 2017 | 903 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 738 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2024 | 8528 | 0.020 |
Why?
|
Monocytes | 1 | 2021 | 2570 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2014 | 957 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20099 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2023 | 3312 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3162 | 0.020 |
Why?
|
Medical Order Entry Systems | 1 | 2016 | 521 | 0.020 |
Why?
|
Adenoma | 1 | 2021 | 2160 | 0.020 |
Why?
|
Histones | 1 | 2021 | 2580 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4124 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2321 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5791 | 0.020 |
Why?
|
Proteome | 1 | 2020 | 1862 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1667 | 0.020 |
Why?
|
DNA Methylation | 1 | 2024 | 4399 | 0.020 |
Why?
|
Base Sequence | 1 | 2020 | 12441 | 0.020 |
Why?
|
Pyrazoles | 1 | 2019 | 2009 | 0.020 |
Why?
|
Peptides | 1 | 2021 | 4358 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5439 | 0.020 |
Why?
|
Palliative Care | 1 | 2024 | 3598 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13510 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3767 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3548 | 0.020 |
Why?
|
Zebrafish | 1 | 2020 | 3007 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3677 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4352 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3032 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2556 | 0.020 |
Why?
|
Homeostasis | 1 | 2019 | 3323 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4948 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 13446 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1509 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4740 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 866 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4369 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10194 | 0.020 |
Why?
|
Proteins | 1 | 2001 | 6032 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12463 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4652 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8002 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5079 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 39970 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2014 | 2910 | 0.020 |
Why?
|
Cytogenetics | 1 | 2005 | 198 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11076 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2021 | 11530 | 0.010 |
Why?
|
Rats | 1 | 2020 | 23741 | 0.010 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2005 | 322 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9326 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 80646 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12954 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13367 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21355 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2961 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11904 | 0.010 |
Why?
|
Urethane | 1 | 2001 | 36 | 0.010 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2001 | 58 | 0.010 |
Why?
|
Aging | 1 | 2020 | 8711 | 0.010 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2005 | 682 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2005 | 1062 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2005 | 1076 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2456 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15601 | 0.010 |
Why?
|
Carcinogens | 1 | 2001 | 452 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2005 | 2510 | 0.010 |
Why?
|
Melanoma | 1 | 2017 | 5709 | 0.010 |
Why?
|
Heart | 1 | 1990 | 4404 | 0.010 |
Why?
|
Thymus Gland | 1 | 2001 | 1243 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39107 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2005 | 2448 | 0.010 |
Why?
|
Trans-Activators | 1 | 2005 | 2856 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2001 | 1674 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2005 | 2803 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6075 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11122 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 4465 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3449 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54426 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2005 | 4937 | 0.010 |
Why?
|
Child | 1 | 1990 | 80156 | 0.000 |
Why?
|
Adolescent | 1 | 1990 | 88324 | 0.000 |
Why?
|